Pharmacokinetics of Aliskiren in Patients with End-Stage Renal Disease Undergoing Haemodialysis

被引：0
|
作者：
Dmytro Khadzhynov
Torsten Slowinski
Ina Lieker
Hans-Hellmut Neumayer
Diego Albrecht
Henk Johan Streefkerk
Sam Rebello
Harm Peters
机构：
[1] Charité Universitätsmedizin Berlin,Department of Nephrology
[2] Humboldt University,Novartis Institutes for Biomedical Research
[3] Translational Science,undefined
来源：
Clinical Pharmacokinetics | 2012年 / 51卷
关键词：
Ezetimibe; Aliskiren; ESRD Patient; Eprosartan; Haemodialysis Session;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：661 / 669
页数：8
相关论文
共 50 条
  • [1] Pharmacokinetics of Aliskiren in Patients with End-Stage Renal Disease Undergoing Haemodialysis
    Khadzhynov, Dmytro
    Slowinski, Torsten
    Lieker, Ina
    Neumayer, Hans-Hellmut
    Albrecht, Diego
    Streefkerk, Henk Johan
    Rebello, Sam
    Peters, Harm
    [J]. CLINICAL PHARMACOKINETICS, 2012, 51 (10) : 661 - 669
  • [2] Venetoclax pharmacokinetics in participants with end-stage renal disease undergoing haemodialysis
    Noorani, Behnam
    Menon, Rajeev M.
    Chen, Xin
    Marsh, Kennan C.
    Huang, Weize
    Gupta, Shelly
    Dobkowska, Edyta
    Marbury, Thomas
    Salem, Ahmed Hamed
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (03) : 748 - 758
  • [3] The pharmacokinetics of etanercept in patients with end-stage renal disease on haemodialysis
    Don, BR
    Spin, G
    Nestorov, I
    Hutmacher, M
    Rose, A
    Kaysen, GA
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2005, 57 (11) : 1407 - 1413
  • [4] Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis
    Parasrampuria, Dolly A.
    Marbury, Thomas
    Matsushima, Nobuko
    Chen, Shuquan
    Wickremasingha, Prachi K.
    He, Ling
    Dishy, Victor
    Brown, Karen S.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2015, 113 (04) : 719 - 727
  • [5] Pharmacokinetics of a parenteral carbapenem, biapenem, in patients with end-stage renal disease and influence of haemodialysis
    Nagashima, S
    Kozawa, O
    Otsuka, T
    Kohno, K
    Minamoto, M
    Yokokawa, M
    Kanamaru, M
    Uematsu, T
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (05) : 839 - 842
  • [6] Frailty in Older Patients with End-Stage Renal Disease and Undergoing Chronic Haemodialysis in Vietnam
    Nguyen, Tan Van
    Pham, Thu Thi Xuan
    Burns, Mason Jenner
    Nguyen, Tu Ngoc
    [J]. DIABETOLOGY, 2023, 4 (03): : 312 - 322
  • [7] Quality of life of patients on haemodialysis for end-stage renal disease
    Cleary, J
    Drennan, J
    [J]. JOURNAL OF ADVANCED NURSING, 2005, 51 (06) : 577 - 586
  • [8] Removal of clodronate by haemodialysis in end-stage renal disease patients
    Beigel, AE
    Rienhoff, E
    Olbricht, CJ
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 (12) : 2266 - 2268
  • [9] INFLAMMATORY MARKERS IN END-STAGE RENAL DISEASE PATIENTS ON HAEMODIALYSIS
    Abdel-Messeih, Phebe Lotfy
    Alkady, Manal Mohamed
    Nosseir, Neveen Mostafa
    Tawfik, Mohamed Said
    [J]. JOURNAL OF MEDICAL BIOCHEMISTRY, 2020, 39 (04) : 481 - 487
  • [10] Pharmacokinetics of rosiglitazone in patients with end-stage renal disease
    Thompson-Culkin, K
    Zussman, B
    Miller, AK
    Freed, MI
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2002, 30 (04) : 391 - 399
12345